Cleared Abbreviated

K990638 - ANEROID SPHYGMOMANOMETER

K990638 is an FDA 510(k) clearance for ANEROID SPHYGMOMANOMETER, manufactured by Genmed, Inc.. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Abbreviated 510(k) pathway after a 223-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1999
Decision
223d
Days
Class 2
Risk

K990638 is an FDA 510(k) clearance for the ANEROID SPHYGMOMANOMETER. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Genmed, Inc. (Baltimore, US). The FDA issued a Cleared decision on October 7, 1999 after a review of 223 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Genmed, Inc. devices

FDA 510(k) Submission Details - K990638

510(k) Number K990638 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 26, 1999
Decision Date October 07, 1999
Days to Decision 223 days
Submission Type Abbreviated
Review Panel Cardiovascular (CV)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
98d slower than avg
Panel avg: 125d · This submission: 223d
Pathway characteristics
Standards-based clearance path.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 846
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K990638.
DIGITAL BLOOD PRESSURE MONITOR, MODEL DS-181
K993890 · Nihon Seimitsu Sokki Co., Ltd. · Dec 1999
DAIWA MODEL 180
K983616 · Daiwa Products, Inc. · Oct 1999
PHYSIOLOGICAL SIGNAL TRANSMITTER AND RECEIVER, MODEL 3810A
K992478 · Hewlett-Packard, Healthcare Solutions Group · Oct 1999
BP-TEL TRANS-TELEPHONIC BLOOD PRESSURE MEASUREMENT SYSTEM
K983717 · Aerotel Medical Systems (1998) , Ltd. · Sep 1999
NIBP AND CO2 OPTIONS FOR THE PHYSIO-CONTROL LIFEPAK 12 DEFIBRILLATOR/MONITOR SYSTEM
K990338 · Physio-Control Corp. · Sep 1999
A&D MEDICAL TM-2430 AND TM-2431 AMBULATORY BLOOD PRESSURE
K992808 · A&D Medical Div. · Sep 1999